Zobrazeno 1 - 10 of 485 pro vyhledávání: '"Satpati, D."'
1
Akademický článek
Peptide-drug conjugate designated for targeted delivery to HER2-expressing cancer cells.
Autor: Sharma AK; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Sharma R; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Chauhan N; Homi Bhabha National Institute, Mumbai, India.; Bio-Organic Division, Bhabha Atomic Research Centre, Mumbai, India., Das A; Homi Bhabha National Institute, Mumbai, India.; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India., Satpati D; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India.
Publikováno v: Journal of peptide science : an official publication of the European Peptide Society [J Pept Sci] 2024 Sep; Vol. 30 (9), pp. e3602. Date of Electronic Publication: 2024 Apr 10.
Zobrazit plný text záznamu
2
Akademický článek
Influence of PEGylation on HER2-targeting retro A9 peptide analogue.
Autor: Yadav SA; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India., Vats VK; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Sharma R; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Mukherjee A; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Satpati D; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India. Electronic address: drishtys@barc.gov.in.
Publikováno v: Nuclear medicine and biology [Nucl Med Biol] 2024 Nov-Dec; Vol. 138-139, pp. 108963. Date of Electronic Publication: 2024 Oct 05.
Zobrazit plný text záznamu
3
Akademický článek
177 Lu-labeling of nuclear localization sequence (NLS)-grafted HER2-receptor affine peptide.
Autor: Yadav SA; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India., Vats VK; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India., Sharma R; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Chauhan N; Bio-organic Division, Bhabha Atomic Research Centre, Mumbai, India., Subramanian M; Bio-organic Division, Bhabha Atomic Research Centre, Mumbai, India., Das A; Protein Crystallography Section, Bio-Science Group, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Satpati D; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India. Electronic address: drishtys@barc.gov.in.
Publikováno v: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2024 Oct 01; Vol. 112, pp. 117883. Date of Electronic Publication: 2024 Aug 21.
Zobrazit plný text záznamu
4
Akademický článek
Nuclear Localization Signal Enhances the Targeting and Therapeutic Efficacy of a Porphyrin-Based Molecular Cargo: A Systemic In Vitro and Ex Vivo Evaluation.
Autor: Kumar N; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, India., Sharma AK; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, India., Guleria M; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, India., Shelar SB; Chemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India., Chakraborty A; Radiation Medicine Centre, Bhabha Atomic Research Centre, Parel, Mumbai 400012, India., Rakshit S; Radiation Medicine Centre, Bhabha Atomic Research Centre, Parel, Mumbai 400012, India., Kolay S; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India., Satpati D; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, India., Das T; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, India.
Publikováno v: Molecular pharmaceutics [Mol Pharm] 2024 May 06; Vol. 21 (5), pp. 2351-2364. Date of Electronic Publication: 2024 Mar 13.
Zobrazit plný text záznamu
5
Akademický článek
Design, synthesis and evaluation of 177 Lu-labeled inverso and retro-inverso A9 peptide variants targeting HER2-overexpression.
Autor: Kumar Sharma A; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Sharma R; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Dev Sarma H; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India., Mukherjee A; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Das T; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Satpati D; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India. Electronic address: drishtys@barc.gov.in.
Publikováno v: Bioorganic chemistry [Bioorg Chem] 2023 Nov; Vol. 140, pp. 106761. Date of Electronic Publication: 2023 Aug 04.
Zobrazit plný text záznamu
6
Akademický článek
Synthesis and 177 Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior Variant.
Autor: Sharma AK; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400085, India.; Homi Bhabha National Institute, Mumbai 400094, India., Sharma R; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400085, India.; Homi Bhabha National Institute, Mumbai 400094, India., Das A; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400085, India.; Homi Bhabha National Institute, Mumbai 400094, India., Chakraborty A; Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400012, India.; Homi Bhabha National Institute, Mumbai 400094, India., Rakshit S; Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400012, India., Sarma HD; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400085, India., Mukherjee A; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400085, India.; Homi Bhabha National Institute, Mumbai 400094, India., Das T; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400085, India.; Homi Bhabha National Institute, Mumbai 400094, India., Satpati D; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, Maharashtra 400085, India.; Homi Bhabha National Institute, Mumbai 400094, India.
Publikováno v: Bioconjugate chemistry [Bioconjug Chem] 2023 Sep 20; Vol. 34 (9), pp. 1576-1584. Date of Electronic Publication: 2023 Jun 28.
Zobrazit plný text záznamu
7
Akademický článek
Targeting HER2-receptors with 177 Lu-labeled triazole stapled cyclic peptidomimetic.
Autor: Kumar Sharma A; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Satpati D; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India. Electronic address: drishtys@barc.gov.in., Sharma R; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Das A; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India., Dev Sarma H; Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai, India., Mukherjee A; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India.
Publikováno v: Bioorganic chemistry [Bioorg Chem] 2023 Jun; Vol. 135, pp. 106503. Date of Electronic Publication: 2023 Mar 29.
Zobrazit plný text záznamu
8
Akademický článek
Assessment of 177 Lu-labeled carboxyl-terminated polyamidoamine (PAMAM) dendrimer-RGD peptide conjugate.
Autor: Vats K; Radiopharmaceuticals Division, Radiochemistry and Isotope Group, Mumbai, India.; Chemical Sciences, Homi Bhabha National Institute, Mumbai, India., Sharma R; Radiopharmaceuticals Division, Radiochemistry and Isotope Group, Mumbai, India.; Chemical Sciences, Homi Bhabha National Institute, Mumbai, India., Sharma AK; Radiopharmaceuticals Division, Radiochemistry and Isotope Group, Mumbai, India.; Chemical Sciences, Homi Bhabha National Institute, Mumbai, India., Sarma HD; Radiation Biology and Health Science Division, Bhabha Atomic Research Centre, Mumbai, India., Satpati D; Radiopharmaceuticals Division, Radiochemistry and Isotope Group, Mumbai, India.; Chemical Sciences, Homi Bhabha National Institute, Mumbai, India.
Publikováno v: Journal of peptide science : an official publication of the European Peptide Society [J Pept Sci] 2022 Feb; Vol. 28 (2), pp. e3366. Date of Electronic Publication: 2021 Aug 30.
Zobrazit plný text záznamu
9
Akademický článek
68 Ga-labeling of internalizing RGD (iRGD) peptide functionalized with DOTAGA and NODAGA chelators.
Autor: Satpati D; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, 400085, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India., Vats K; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, 400085, India., Sharma R; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, 400085, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India., Sarma HD; Radiation Biology and Health Science Division, Bhabha Atomic Research Centre, Mumbai, 400085, India., Dash A; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, 400085, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India.
Publikováno v: Journal of peptide science : an official publication of the European Peptide Society [J Pept Sci] 2020 Mar; Vol. 26 (3), pp. e3241. Date of Electronic Publication: 2020 Jan 26.
Zobrazit plný text záznamu
10
Akademický článek
[ 99m Tc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers.
Autor: Vats K; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India., Chakraborty A; Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India., Rakshit S; Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India., Damle A; Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India., Sarma HD; Radiation Biology and Health Science Division, Bhabha Atomic Research Centre, Mumbai, India., Satpati D; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India. Electronic address: drishtys@barc.gov.in.
Publikováno v: Nuclear medicine and biology [Nucl Med Biol] 2023 Mar-Apr; Vol. 118-119, pp. 108331. Date of Electronic Publication: 2023 Mar 10.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje